394 related articles for article (PubMed ID: 14734334)
1. Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review.
Vesely SK; Perdue JJ; Rizvi MA; Terrell DR; George JN
Ann Intern Med; 2004 Jan; 140(2):112-20. PubMed ID: 14734334
[TBL] [Abstract][Full Text] [Related]
2. Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review.
Gibson M; Sehon JK; White S; Zibari GB; Johnson LW
Am Surg; 2000 Oct; 66(10):952-4; discussion 955. PubMed ID: 11261623
[TBL] [Abstract][Full Text] [Related]
3. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases.
Schiavotto C; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):22-8. PubMed ID: 8039754
[TBL] [Abstract][Full Text] [Related]
4. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
5. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura.
Arnold DM; Dentali F; Crowther MA; Meyer RM; Cook RJ; Sigouin C; Fraser GA; Lim W; Kelton JG
Ann Intern Med; 2007 Jan; 146(1):25-33. PubMed ID: 17200219
[TBL] [Abstract][Full Text] [Related]
6. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura.
Stasi R; Stipa E; Masi M; Cecconi M; Scimò MT; Oliva F; Sciarra A; Perrotti AP; Adomo G; Amadori S
Am J Med; 1995 May; 98(5):436-42. PubMed ID: 7733121
[TBL] [Abstract][Full Text] [Related]
7. Immune thrombocytopenic purpura in adults.
Godeau B; Provan D; Bussel J
Curr Opin Hematol; 2007 Sep; 14(5):535-56. PubMed ID: 17934364
[TBL] [Abstract][Full Text] [Related]
8. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
[TBL] [Abstract][Full Text] [Related]
9. Summaries for patients. Treatment options for idiopathic thrombocytopenic purpura when splenectomy is ineffective.
Ann Intern Med; 2004 Jan; 140(2):I38. PubMed ID: 14734357
[No Abstract] [Full Text] [Related]
10. Cyclosporin A as an immunosuppressive treatment modality for patients with refractory autoimmune thrombocytopenic purpura after splenectomy failure.
Zver S; Zupan IP; Cernelc P
Int J Hematol; 2006 Apr; 83(3):238-42. PubMed ID: 16720554
[TBL] [Abstract][Full Text] [Related]
11. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D.
Andrew M; Blanchette VS; Adams M; Ali K; Barnard D; Chan KW; DeVeber LB; Esseltine D; Israels S; Korbrinsky N
J Pediatr; 1992 Apr; 120(4 Pt 1):522-7. PubMed ID: 1313096
[TBL] [Abstract][Full Text] [Related]
12. Management of patients with refractory immune thrombocytopenic purpura.
George JN
J Thromb Haemost; 2006 Aug; 4(8):1664-72. PubMed ID: 16879206
[TBL] [Abstract][Full Text] [Related]
13. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
Schiavotto C; Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
[TBL] [Abstract][Full Text] [Related]
14. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications.
Kojouri K; Vesely SK; Terrell DR; George JN
Blood; 2004 Nov; 104(9):2623-34. PubMed ID: 15217831
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura.
Kojouri K; George JN
Int J Hematol; 2005 Feb; 81(2):119-25. PubMed ID: 15765779
[TBL] [Abstract][Full Text] [Related]
16. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Schweizer C; Reu FJ; Ho AD; Hensel M
Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
[TBL] [Abstract][Full Text] [Related]
17. Results and prognostic factors of splenectomy in idiopathic thrombocytopenic purpura.
Winde G; Schmid KW; Lügering N; Fischer R; Brandt B; Berns T; Bünte H
J Am Coll Surg; 1996 Dec; 183(6):565-74. PubMed ID: 8957458
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic splenectomy for immune thrombocytopenic purpura in patients with severe refractory thrombocytopenia.
Keidar A; Sagi B; Szold A
Pathophysiol Haemost Thromb; 2003; 33(2):116-9. PubMed ID: 14624054
[TBL] [Abstract][Full Text] [Related]
19. Partial splenic embolization for the treatment of chronic idiopathic thrombocytopenic purpura.
Miyazaki M; Itoh H; Kaiho T; Ohtawa S; Ambiru S; Hayashi S; Nakajima N; Oh H; Asai T; Iseki T
AJR Am J Roentgenol; 1994 Jul; 163(1):123-6. PubMed ID: 8010197
[TBL] [Abstract][Full Text] [Related]
20. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP).
Schwartz J; Leber MD; Gillis S; Giunta A; Eldor A; Bussel JB
Am J Hematol; 2003 Feb; 72(2):94-8. PubMed ID: 12555211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
